ASX:ANP

ANTISENSE THERAPEUTICS LIMITED

ANTISENSE THERAPEUTICS LIMITED has not announced any capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise

< $50k

Investors Interested in Next Raise

< 10

How Fresh Equities Works

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

2. View Terms

View the full term sheet for the capital raise.

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

Company Overview

Antisense Therapeutics Limited (ANP.ASX) is an Australian publicly traded biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.

Type

Listed Company

GICS Sub-industry

Pharmaceuticals

Head Office

6 Wallace Ave, Toorak VIC 3142, Australia

Website

www.antisense.com.au

Pharmaceuticals

Health Care

Biotech

Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Fresh Equities does not have ANTISENSE THERAPEUTICS LIMITED quarterly cash flows data.

Directors

Fresh Equities does not have ANTISENSE THERAPEUTICS LIMITED directors data.

Announcements

Market Sensitive

From

Fresh Equities does not have ANTISENSE THERAPEUTICS LIMITED announcements data.

News

Fresh Equities does not have ANTISENSE THERAPEUTICS LIMITED news data.